These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33423156)

  • 1. Off-the-Shelf, Immune-Compatible Human Embryonic Stem Cells Generated Via CRISPR-Mediated Genome Editing.
    Kim A; Lee KG; Kwon Y; Lee KI; Yang HM; Habib O; Kim J; Kim ST; Kim SJ; Kim JS; Hwang DY
    Stem Cell Rev Rep; 2021 Jun; 17(3):1053-1067. PubMed ID: 33423156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome editing HLA alleles for a pilot immunocompatible hESC line in a Chinese hESC bank for cell therapies.
    Ji TT; Niu SS; Fang MH; Xu LX; Wang X; Zou J; Xu F; Zhang M; Niu R; Wu J; Wang L; Li ZK; Yang YG; Hao J; Li W; Hu Z; Zhou Q
    Cell Prolif; 2023 May; 56(5):e13471. PubMed ID: 37199039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
    Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
    Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High quality clinical grade human embryonic stem cell lines derived from fresh discarded embryos.
    Ye J; Bates N; Soteriou D; Grady L; Edmond C; Ross A; Kerby A; Lewis PA; Adeniyi T; Wright R; Poulton KV; Lowe M; Kimber SJ; Brison DR
    Stem Cell Res Ther; 2017 Jun; 8(1):128. PubMed ID: 28583200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 28 human embryonic stem cell lines for use as unrelated donors in stem cell therapy: implications of HLA and ABO genotypes.
    Lee JE; Kang MS; Park MH; Shim SH; Yoon TK; Chung HM; Lee DR
    Cell Transplant; 2010; 19(11):1383-95. PubMed ID: 20587141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application.
    Kitano Y; Nishimura S; Kato TM; Ueda A; Takigawa K; Umekage M; Nomura M; Kawakami A; Ogawa H; Xu H; Hotta A; Takasu N; Tsukahara M
    Mol Ther Methods Clin Dev; 2022 Sep; 26():15-25. PubMed ID: 35755947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility.
    Xu H; Wang B; Ono M; Kagita A; Fujii K; Sasakawa N; Ueda T; Gee P; Nishikawa M; Nomura M; Kitaoka F; Takahashi T; Okita K; Yoshida Y; Kaneko S; Hotta A
    Cell Stem Cell; 2019 Apr; 24(4):566-578.e7. PubMed ID: 30853558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of universal human embryonic stem cell lines.
    Kong M; Zhou D
    Immunol Lett; 2021 Feb; 230():59-62. PubMed ID: 33309828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen Presentation by Individually Transferred HLA Class I Genes in HLA-A, HLA-B, HLA-C Null Human Cell Line Generated Using the Multiplex CRISPR-Cas9 System.
    Hong CH; Sohn HJ; Lee HJ; Cho HI; Kim TG
    J Immunother; 2017; 40(6):201-210. PubMed ID: 28604557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-mediated genome editing in naïve human embryonic stem cells.
    Jacobs EZ; Warrier S; Volders PJ; D'haene E; Van Lombergen E; Vantomme L; Van der Jeught M; Heindryckx B; Menten B; Vergult S
    Sci Rep; 2017 Nov; 7(1):16650. PubMed ID: 29192200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of Retinal Pigment Epithelial Cells Derived from Human Embryonic Stem Cells Lacking Human Leukocyte Antigen Class I and II.
    Petrus-Reurer S; Winblad N; Kumar P; Gorchs L; Chrobok M; Wagner AK; Bartuma H; Lardner E; Aronsson M; Plaza Reyes Á; André H; Alici E; Kaipe H; Kvanta A; Lanner F
    Stem Cell Reports; 2020 Apr; 14(4):648-662. PubMed ID: 32197113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells.
    Deuse T; Seifert M; Tyan D; Tsao PS; Hua X; Velden J; Eiermann T; Volk HD; Reichenspurner H; Robbins RC; Schrepfer S
    J Cell Sci; 2011 Sep; 124(Pt 17):3029-37. PubMed ID: 21878509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen I knockdown human embryonic stem cells induce host ignorance and achieve prolonged xenogeneic survival.
    Deuse T; Seifert M; Phillips N; Fire A; Tyan D; Kay M; Tsao PS; Hua X; Velden J; Eiermann T; Volk HD; Reichenspurner H; Robbins RC; Schrepfer S
    Circulation; 2011 Sep; 124(11 Suppl):S3-9. PubMed ID: 21911816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise Review: One Stone for Multiple Birds: Generating Universally Compatible Human Embryonic Stem Cells.
    Zheng D; Wang X; Xu RH
    Stem Cells; 2016 Sep; 34(9):2269-75. PubMed ID: 27251112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of NERCe003-A-3, a p53 compound heterozygous mutation human embryonic stem cell line, by CRISPR/Cas9 editing.
    Li Y; Huang C; Zha L; Kong M; Yang Q; Zhu Y; Peng Y; Ouyang Q; Lu G; Lin G; Zhou D
    Stem Cell Res; 2019 Jan; 34():101371. PubMed ID: 30658254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of universal and hypoimmunogenic human pluripotent stem cells.
    Ye Q; Sung TC; Yang JM; Ling QD; He Y; Higuchi A
    Cell Prolif; 2020 Dec; 53(12):e12946. PubMed ID: 33174655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrate CRISPR/Cas9 for protein expression of HLA-B*38:68Q via precise gene editing.
    Yin Y; Reed EF; Zhang Q
    Sci Rep; 2019 May; 9(1):8067. PubMed ID: 31147565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives.
    Zhao L; Teklemariam T; Hantash BM
    Stem Cell Res; 2014 Sep; 13(2):342-54. PubMed ID: 25218797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Immunological Tolerance by HLA-G1 from Neural Progenitor Cells (NPCs) Derived from Human Embryonic Stem Cells (hESCs).
    Zhao HX; Jiang F; Zhu YJ; Wang L; Li K; Li Y; Wang XH; Li LS; Yao YQ
    Cell Physiol Biochem; 2017; 44(4):1435-1444. PubMed ID: 29186714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoimmunogenic Human Pluripotent Stem Cells as a Powerful Tool for Liver Regenerative Medicine.
    Trionfini P; Romano E; Varinelli M; Longaretti L; Rizzo P; Giampietro R; Caroli A; Aiello S; Todeschini M; Casiraghi F; Remuzzi G; Benigni A; Tomasoni S
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.